http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1493926_PMID29129512

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID242348988_AID1493926_PMID29129512_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103164874_AID1493926_PMID29129512_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID194168333_AID1493926_PMID29129512_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID336870280_AID1493926_PMID29129512_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103724173_AID1493926_PMID29129512_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID336870129_AID1493926_PMID29129512_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103611439_AID1493926_PMID29129512_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID404652767_AID1493926_PMID29129512_VALUE8
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9H244
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Antagonist activity at P2Y12 in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation at 10 uM pretreated for 30 mins followed by ADP addition measured after 5 mins by light transmission aggregometric analysis
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID336870280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID336870129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103611439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID404652767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242348988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID194168333
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103724173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103164874
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1493926

Total number of triples: 21.